5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.70%
Negative revenue growth while UPM.HE stands at 2.49%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.46%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
55.92%
EBIT growth above 1.5x UPM.HE's 1.48%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
55.92%
Operating income growth above 1.5x UPM.HE's 1.48%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
86.69%
Net income growth above 1.5x UPM.HE's 3.23%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
66.67%
EPS growth above 1.5x UPM.HE's 3.45%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
66.67%
Diluted EPS growth above 1.5x UPM.HE's 3.45%. David Dodd would see if there's a robust moat protecting these shareholder gains.
12.01%
Share change of 12.01% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
12.01%
Diluted share change of 12.01% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
71.69%
OCF growth under 50% of UPM.HE's 200.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
-407.87%
Negative FCF growth while UPM.HE is at 715.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-18.90%
Negative 10Y revenue/share CAGR while UPM.HE stands at 10.81%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-43.53%
Negative 5Y CAGR while UPM.HE stands at 11.21%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-10.34%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
353.57%
Positive long-term OCF/share growth while UPM.HE is negative. John Neff would see a structural advantage in sustained cash generation.
285.47%
5Y OCF/share CAGR 1.25-1.5x UPM.HE's 209.59%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
256.35%
3Y OCF/share CAGR above 1.5x UPM.HE's 140.00%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
152.33%
Below 50% of UPM.HE's 628.48%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
600.00%
Positive 5Y CAGR while UPM.HE is negative. John Neff might view this as a strong mid-term relative advantage.
-64.97%
Negative 3Y CAGR while UPM.HE is 81.18%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-22.27%
Negative 5Y equity/share growth while UPM.HE is at 7.25%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
12.10%
3Y equity/share CAGR above 1.5x UPM.HE's 1.33%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.47%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-8.40%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-4.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.68%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-2.07%
We’re deleveraging while UPM.HE stands at 2.39%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.08%
SG&A growth of 3.08% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.